John M. Langstaff
Direttore/Membro del Consiglio presso Therapure Biopharma, Inc.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Bhupinder Brar | M | - |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | - |
Lloyd Segal | M | 60 |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 8 anni |
Dirk Alkema | M | - |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 17 anni |
Gabriel de Alba | M | 51 |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 17 anni |
Brian Harold Hadfield | M | 71 |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | - |
Ian Mumford | M | - |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 8 anni |
Johan Vandersande | M | - |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 8 anni |
Keith Tucker | M | - |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 7 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
R. Scott Lillibridge | M | 70 | - | |
James Moodie Rae | M | - | 8 anni | |
Michael Graham | M | - | 8 anni | |
Andrew Storey | M | - | - | |
Donald Bruce Burlington | M | 75 | - | |
Francis J. St. Hilaire | M | - | - | |
John Robert Lavery | M | - | - | |
John A. Vivash | M | - | - | |
Nicholas Green | M | 60 |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 9 anni |
R. Craig Baxter | M | 68 | - | |
James Pasieka | M | 70 |
University of Manitoba
| 7 anni |
Jacob M. Kay | M | 83 | - | |
Philip R. Johnson | M | - | - | |
Paul Brisebois | M | - | - | |
Donald Hrap | M | 64 |
University of Manitoba
| 4 anni |
Marvin Richardson | M | - |
University of Manitoba
| 4 anni |
Paul Champagne | M | 65 |
University of Manitoba
| 4 anni |
Brock J. Wright | M | 64 |
University of Manitoba
| 3 anni |
Teck Lean Teong | M | 63 |
University of Manitoba
| 4 anni |
Jim Dale | M | - |
University of Manitoba
| 4 anni |
Edwin Mah | M | 63 |
University of Manitoba
| 4 anni |
And Yeng Kheoh | F | 67 |
University of Manitoba
| 4 anni |
Donald James Findlay | M | 77 |
University of Manitoba
| 1 anni |
Larry Philip Fontaine | M | 80 |
University of Manitoba
| 4 anni |
Brian Maynard | M | 64 |
University of Manitoba
| 4 anni |
Sylvia Barnes | F | 67 |
University of Manitoba
| 4 anni |
Kenneth Holmes | M | 68 |
University of Manitoba
| 3 anni |
Bruce Warnock | M | - |
University of Manitoba
| 3 anni |
Dwayne Car | M | - |
University of Manitoba
| 1 anni |
Maxwell Polinsky | M | 66 |
University of Manitoba
| 4 anni |
Doug Tkachuk | M | - |
University of Manitoba
| 3 anni |
Ray Kohanik | M | - |
University of Manitoba
| 4 anni |
Safa'a Al-Rais | M | - |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 11 anni |
Shu Wing Liu | M | 68 |
University of Manitoba
| 4 anni |
Eric Wallman | M | - |
University of Manitoba
| 4 anni |
Sonia Tibbatts | F | 69 |
University of Manitoba
| 1 anni |
Stanley Stewin | M | - |
University of Manitoba
| 4 anni |
Dina Iezzi | F | - |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 11 anni |
Raj Puri | M | - |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 10 anni |
Trevor Young | M | - |
University of Manitoba
| 4 anni |
Tai Hock Dang | M | 66 |
University of Manitoba
| 4 anni |
David N. Bell | M | - |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 13 anni |
Keith Wilford | M | - |
University of Manitoba
| 4 anni |
Glen Hodgson | M | - |
University of Manitoba
| 3 anni |
Chris Sinclair | M | - | - | |
Gregory P. Downey | M | - |
University of Manitoba
| 4 anni |
Robert Nickel | M | - |
University of Manitoba
| 4 anni |
Les Deezar | M | - | - | |
David Washenfelder | M | - |
University of Manitoba
| 4 anni |
Donald Jeffrey Gawick | M | 66 |
University of Manitoba
| 4 anni |
Laura Saward | M | - | 10 anni | |
Peter K. Dorrins | M | - |
University of Manitoba
| 4 anni |
Anatoly Langer | M | - |
University of Manitoba
| 3 anni |
Wai Foon Tan | F | 65 |
University of Manitoba
| 4 anni |
Jay M. Zammit | M | 64 |
University of Manitoba
| 4 anni |
Glenn Asham | M | - |
University of Manitoba
| 4 anni |
Brock Bulbuck | M | 64 |
University of Manitoba
| 4 anni |
Alan Lowe | M | 62 |
University of Manitoba
| 4 anni |
Ronald Mathison | M | 67 |
University of Manitoba
| 4 anni |
Constantine Buzunis | M | 66 |
University of Manitoba
| 4 anni |
Ernie Peter Friesen | M | - |
University of Manitoba
| 4 anni |
John S. Pollard | M | 62 |
University of Manitoba
| 4 anni |
Wayne S. Demkey | M | - |
University of Manitoba
| 4 anni |
Bruce J. Hoeschen | M | - |
University of Manitoba
| 4 anni |
Glen Clark Rattray | M | 61 |
University of Manitoba
| 4 anni |
Michael Spino | M | - | - | |
Claudio A. Ghersinich | M | 67 |
University of Manitoba
| 4 anni |
Tom Bradley | M | - |
University of Manitoba
| 4 anni |
Edward Sonshine | M | 77 | 1 anni | |
Jeremy Curnock-Cook | M | 75 | 3 anni | |
Donald Streuber | M | 66 |
University of Manitoba
| 4 anni |
Brian D. Gordon | M | 67 |
University of Manitoba
| 3 anni |
Bruce Mackenzie Rothney | M | - |
University of Manitoba
| 4 anni |
Darrin Robert Drall | M | - |
University of Manitoba
| 4 anni |
Gary W. Hayes | M | - |
University of Manitoba
| 4 anni |
John Sanderson | M | 73 |
University of Manitoba
| 1 anni |
David Cortens | M | - |
University of Manitoba
| 4 anni |
Jeremy B. Desai | M | - | - | |
Richard Thompson | M | 68 |
University of Manitoba
| 4 anni |
David Stephen Cymbalisty | M | 60 |
University of Manitoba
| 4 anni |
Warren Bates | M | - |
University of Manitoba
| 4 anni |
Vicki Wolff-Long | M | - | - | |
Newton G. Z. Glassman | M | 60 |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | - |
Timothy Hodgson | M | 63 |
University of Manitoba
| 4 anni |
Ronald Gregory Panchuk | M | 65 |
University of Manitoba
| 3 anni |
Grant McClarty | M | - | 5 anni | |
David A. Long | M | - |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 5 anni |
Peter Gustavson | M | 67 |
University of Manitoba
| 4 anni |
Don McDonald | M | - |
University of Manitoba
| 4 anni |
Kenneth Hillier | M | 63 |
University of Manitoba
| 4 anni |
Garnet Dawson | M | 66 |
University of Manitoba
| 4 anni |
Gerry D. White | M | 68 |
University of Manitoba
| 3 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Canada | 100 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- John M. Langstaff
- Contatti personali